Related Experiment Video
Updated: May 7, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Novel oncoprotein EPS8: a new target for anticancer therapy
Yu-Hua Li1, Tong-Yuan Xue, Ying-Zhi He
1Department of Hematology, Zhujiang Hospital, Southern Medical University, 510282 Guangzhou, China.
Abstract:
EPS8 was first identified as a tyrosine kinase substrate, that plays a role in EGFR-mediated mitogenic signaling. Recent research has shown that EPS8 is overexpressed in most types of cancer, for example breast cancer, colon cancer, cervical cancer and even hematologic malignancies. EPS8 is involved in many signaling pathways related to tumorigenesis, proliferation, migration and metastasis, and is a biomarker for poor prognosis of cancer patients. This review aims to provide a comprehensive picture of the role of EPS8 in cellular processes and its significance to tumorigenesis. Furthermore, this review focuses on the potential role of EPS8 as a therapeutic cancer target.
Insights
The EPS8 protein is overexpressed in many cancers and drives tumor growth and spread. Targeting EPS8 may offer a new therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Epidermal growth factor receptor (EGFR) substrate 8 (EPS8) is a tyrosine kinase substrate involved in EGFR-mediated mitogenic signaling.
- EPS8 is frequently overexpressed in various cancers, including breast, colon, and cervical cancers, as well as hematologic malignancies.
- Its involvement in key cellular processes like tumorigenesis, proliferation, migration, and metastasis highlights its significance in cancer progression.
Purpose of the Study:
- To provide a comprehensive overview of EPS8's role in cellular functions.
- To elucidate the significance of EPS8 in tumorigenesis.
- To explore the potential of EPS8 as a therapeutic target for cancer.
Main Methods:
- Literature review of existing research on EPS8.
- Analysis of signaling pathways involving EPS8.
- Evaluation of EPS8's role in cancer progression and prognosis.
Main Results:
- EPS8 overexpression is linked to poor prognosis in cancer patients.
- EPS8 participates in multiple signaling pathways crucial for cancer development.
- EPS8's functions extend to cell proliferation, migration, and metastasis.
Conclusions:
- EPS8 plays a critical role in various cellular processes relevant to cancer.
- The overexpression and functional significance of EPS8 position it as a potential therapeutic target.
- Targeting EPS8 may represent a promising strategy for cancer therapy.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression

